Atria Investments LLC Cardiol Therapeutics Inc. Transaction History
Atria Investments LLC
- $7.93 Billion
- Q2 2025
A detailed history of Atria Investments LLC transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Atria Investments LLC holds 96,342 shares of CRDL stock, worth $108,866. This represents 0.0% of its overall portfolio holdings.
Number of Shares
96,342
Previous 139,053
30.72%
Holding current value
$108,866
Previous $134,000
2.24%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding CRDL
# of Institutions
43Shares Held
6.74MCall Options Held
37.6KPut Options Held
0-
Tejara Capital LTD London, X03.27MShares$3.69 Million2.06% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD857KShares$968,8480.22% of portfolio
-
Pvg Asset Management Corp Golden, CO437KShares$494,2191.99% of portfolio
-
Lion Street Advisors, LLC340KShares$384,2280.15% of portfolio
-
Mmcap International Inc. Spc Grand Cayman, E9293KShares$331,1530.15% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $70M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...